COPD is often associated with acute exacerbations of symptoms, which are major events in the course of the disease. Undermine the quality of life.
It has been shown that more exacerbations (more than 2.9 per year) leads to a faster decline in FEV1. The cost of treatment of exacerbations account for almost 50% of the total cost.